Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Authors: Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston., Yau C; Department of Surgery, University of California, San Francisco., Chen YY; Department of Pathology, University of California, San Francisco., Balassanian R; Department of Pathology, University of California, San Francisco., Klein ME; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis., Pusztai L; Department of Medicine, Medical Oncology, Yale University, New Haven, Connecticut., Nanda R; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois., Parker BA; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla., Datnow B; Department of Pathology, University of California, San Diego, La Jolla., Krings G; Department of Pathology, University of California, San Francisco., Wei S; Department of Anatomic Pathology, University of Alabama at Birmingham., Feldman MD; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia., Duan X; Department of Pathology, Loyola University, Chicago, Illinois., Chen B; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Sattar H; Department of Pathology, University of Chicago, Chicago, Illinois., Khazai L; Department of Pathology, Moffitt Cancer Center, Tampa, Florida., Zeck JC; Department of Pathology, Georgetown University, Washington, DC., Sams S; Department of Pathology, University of Colorado Anschutz Medical Center, Aurora., Mhawech-Fauceglia P; Department of Pathology, University of Southern California, Los Angeles., Rendi M; Department of Anatomic Pathology, University of Washington, Seattle., Sahoo S; Department of Pathology, University of Texas Southwestern, Dallas., Ocal IT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona., Fan F; Department of Pathology, University of Kansas Medical Center, Kansas City., LeBeau LG; Department of Pathology, University of Arizona Health Sciences, Tucson., Vinh T; Department of Pathology, Inova Health System, Fairfax, Virginia., Troxell ML; Department of Pathology, Oregon Health and Science University, Portland., Chien AJ; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco., Wallace AM; Department of Surgery, University of California, San Diego, La Jolla., Forero-Torres A; Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham., Ellis E; Medical Oncology, Swedish Cancer Institute, Seattle, Washington., Albain KS; Division of Hematology-Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois., Murthy RK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota., Liu MC; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Haley BB; Division of Hematology-Oncology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas., Elias AD; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora., Clark AS; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia., Kemmer K; Division of Hematology-Oncology, Department of Medicine, Oregon Health & Science University, Portland., Isaacs C; Division of Hematology-Oncology, Department of Medicine, Georgetown University, Washington, DC., Lang JE; Department of Surgery, University of Southern California, Los Angeles., Han HS; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida., Edmiston K; Department of Surgery, Inova Schar Cancer Institute, Fairfax, Virginia., Viscusi RK; Department of Surgery, University of Arizona Health Sciences, Tucson, Arizona., Northfelt DW; Department of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona., Khan QJ; Division of Oncology, Department of Medicine, University of Kansas, Kansas City., Leyland-Jones B; Medical Oncology, Avera Cancer Institute, Sioux Falls, South Dakota., Venters SJ; Department of Laboratory Medicine, University of California, San Francisco., Shad S; Department of Surgery, University of California, San Francisco., Matthews JB; Department of Surgery, University of California, San Francisco., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California., Buxton M; Berry Consultants, LLC, Houston, Texas., Asare AL; Quantum Leap Healthcare Collaborative, San Francisco, California., Rugo HS; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco., Schwab RB; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla., Helsten T; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla., Hylton NM; Department of Radiology and Biomedical Imaging, University of California, San Francisco., van 't Veer L; Department of Laboratory Medicine, University of California, San Francisco., Perlmutter J; Gemini Group, Ann Arbor, Michigan., DeMichele AM; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia., Yee D; Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis., Berry DA; Berry Consultants, LLC, Houston, Texas., Esserman LJ; Department of Surgery, University of California, San Francisco.
Source: JAMA oncology [JAMA Oncol] 2021 Nov 01; Vol. 7 (11), pp. 1654-1663.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2374-2445
DOI:10.1001/jamaoncol.2021.3690